The Oncology Institute, Inc. (TOI) Reports Q1 Loss of $0.21, provides guidance
The Oncology Institute, Inc. (NASDAQ: TOI) reported Q1 EPS of ($0.21). Revenue for the quarter came in at $104.4 million, versus $0 reported last year.
GUIDANCE:
The Oncology Institute, Inc. sees FY2025 revenue of $460-480 million, versus the consensus of $482.8 million.
For earnings history and earnings-related data on The Oncology Institute, Inc. (TOI) click here.
